NCT00528060View on ClinicalTrials.gov

Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
HIV Infections
Interventions
DRUG

Atazanavir

2pills/day

DRUG

Ritonavir

1 pill/day

DRUG

Tenofovir/emtricitabine

1 pill/day

Trial Locations (2)

75877

Hopital Bichat CIC, Paris

94275

Hopital du Kremlin Bicêtre Service de médecine interne, Kremlin Bicëtre

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV